REBECA DEMOSS: Open Payments
NPI 1477986115 · LAWRENCEBURG, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 13 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $248 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 4 | $87 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $44 |
| Pulmonx Corporation | 1 | $27 |
| Amgen Inc. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
Products named: Ohtuvayre, NUCALA, GLASSIA, CHARTIS CATHETER, TEZSPIRE, DUPIXENT.
Industry payments across IN — which companies pay providers there.
